ASPNAT and non-small cell lung carcinoma: Elevated levels of the metabolite N-acetylaspartate and the enzyme responsible for its production, N-acetylaspartate synthetase (NAT8L), have been observed in non-small cell lung cancer (NSCLC) and advanced ovarian tumours [153,154].